Evaluation Study on Corneal Lens for Vision Correction

February 2, 2014 updated by: FORSIGHT Vision3
The objective of this study is to evaluate the fitting and visual outcomes of Nexis Lens, made of silicone commonly used in the contact lens industry, on healthy eye with or without astigmatism.

Study Overview

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Fremont, California, United States, 94538
        • Cliff Leong
      • Fremont, California, United States, 94538
        • Sara Chiu
      • Livermore, California, United States, 94550
        • John Michelsen
      • Menlo Park, California, United States, 94025
        • Nexis Vision
      • San Mateo, California, United States, 94401
        • Nick Chan
      • Stockton, California, United States, 95219
        • Josephine Vo-Laurel

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Patient with good corneal health
  2. Age 18-65.
  3. Patients able to understand the requirements of the study and willing to follow study instructions, to provide written informed consent to participate, and who agree to comply with all study requirements.
  4. Best corrected visual acuity of 20/20 or better in the study eye/s

Exclusion Criteria:

  1. Any other anterior segment abnormality.
  2. No previous corneal procedures, including Laser Vision Correction.
  3. Any abnormalities associated with the eye lids.
  4. Clinically significant inflammation or infection within six (6) months prior to study.
  5. Uncontrolled systemic disease (e.g., diabetes, hypertension, etc.) in the opinion of the Investigator.
  6. Participation in any study involving an investigational drug or device within the past 30 calendar days, or ongoing participation in a study with an investigational material except studies using corneal lenses.
  7. Intolerance or hypersensitivity to topical anesthetics, fluorescein, or components of the material.
  8. Specifically known intolerance or hypersensitivity to contact lenses.
  9. Any condition that, in the opinion of the investigator, would jeopardize the safety of the patient.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Astigmatic Correction Lens
Nexis ACCL lenses vs commercial Toric Lenses
Astigmatic refractive error correction
Active Comparator: Toric Soft Contact Lenses
commercial toric soft contact lenses
astigmatism correction using toric optics

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Visual Acuity
Time Frame: 30 mins
30 mins

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ashley Tuan, OD, PhD, Nexisvision

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2013

Primary Completion (Actual)

November 1, 2013

Study Completion (Actual)

December 1, 2013

Study Registration Dates

First Submitted

January 30, 2014

First Submitted That Met QC Criteria

February 2, 2014

First Posted (Estimate)

February 4, 2014

Study Record Updates

Last Update Posted (Estimate)

February 4, 2014

Last Update Submitted That Met QC Criteria

February 2, 2014

Last Verified

January 1, 2014

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CL001

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Astigmatism

Clinical Trials on Astigmatic Correction Lens (Nexis ACCL lenses)

3
Subscribe